ClinicalTrials.Veeva

Menu

The Value of Artificial Intelligence-based 18F-FDG PET/CT in Diferential Diagnosis, Efficacy Prediction and Prognosis Prediction of T-NK Cell Lymphoma: a Clinical Study

Shanghai Jiao Tong University logo

Shanghai Jiao Tong University

Status

Not yet enrolling

Conditions

T-NK Cell Lymphoma

Study type

Observational

Funder types

Other

Identifiers

NCT06747299
RuijinH 2024-349

Details and patient eligibility

About

Based on the PET/CT imaging data of patients with T-NK cell lymphoma, machine learning and deep learning methods are used to extract imaging features, establish a T-NK cell lymphoma prediction model, and provide more scientific and accurate prognosis prediction for the clinic.

Full description

This study adopts a multicenter retrospective cohort study design,we provided PET/CT of 200 patients with T-NK cell lymphoma as an external validation set for model validation.

Enrollment

200 estimated patients

Sex

All

Ages

18 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Pathological histology confirmed as T-NK Cell Lymphoma; 2.18F-FDG PET/CT examination before treatment; 3. Using modern best practice treatment options; 4. Complete clinicopathological and follow-up data were obtained.

Exclusion criteria

  1. The patient had previously received antitumor therapy;
  2. The patient had a history of other tumors;
  3. Incomplete clinical information or imaging data;
  4. Concomitant other malignant tumors.

Trial design

200 participants in 1 patient group

patients diagnosis of T-NK cell lymphoma

Trial contacts and locations

1

Loading...

Central trial contact

Guo rui Deputy director

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems